TMEM150C

gene
On this page

Also known as DRAM4FLJ12993TTN3

Summary

TMEM150C (transmembrane protein 150C, HGNC:37263) is a protein-coding gene on chromosome 4q21.22, encoding Transmembrane protein 150C (B9EJG8). Nonselective cationic channel with high permeability to Ca(2+).

This gene encodes a transmembrane protein component of a mechanosensitve ion channel that is activated by mechanical stimuli in various cell types and confers slowly adapting, mechanically activated currents in dorsal root ganglion neurons. Mechanically activated ion channels are sensors that are critical for hearing, touch, pain, and blood pressure regulation.

Source: NCBI Gene 441027 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 29 total
  • MANE Select transcript: NM_001080506

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:37263
Approved symbolTMEM150C
Nametransmembrane protein 150C
Location4q21.22
Locus typegene with protein product
StatusApproved
AliasesDRAM4, FLJ12993, TTN3
Ensembl geneENSG00000249242
Ensembl biotypeprotein_coding
OMIM617292
Entrez441027

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000449862, ENST00000454948, ENST00000508701, ENST00000515780

RefSeq mRNA: 3 — MANE Select: NM_001080506 NM_001080506, NM_001353454, NM_001353455

CCDS: CCDS47087

Canonical transcript exons

ENST00000449862 — 8 exons

ExonStartEnd
ENSE000016183668249006182490238
ENSE000016336358249606882496195
ENSE000016509978250289582502927
ENSE000016675888250457882504667
ENSE000016740098248317682485719
ENSE000016965408250272782502794
ENSE000017082068250305982503112
ENSE000020841898256190682561988

Expression profiles

Bgee: expression breadth ubiquitous, 251 present calls, max score 99.00.

FANTOM5 (CAGE): breadth broad, TPM avg 4.8078 / max 173.3095, expressed in 790 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
528563.9328743
528600.3543172
528590.2952157
528570.2017116
528580.02388

Top tissues by expression

255 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
corpus epididymisUBERON:000435999.00gold quality
cauda epididymisUBERON:000436098.09gold quality
Brodmann (1909) area 23UBERON:001355495.58gold quality
caput epididymisUBERON:000435893.87gold quality
left ventricle myocardiumUBERON:000656693.45gold quality
kidney epitheliumUBERON:000481992.94silver quality
buccal mucosa cellCL:000233692.40gold quality
right adrenal gland cortexUBERON:003582791.97gold quality
adrenal cortexUBERON:000123591.68gold quality
cortical plateUBERON:000534391.68gold quality
left adrenal glandUBERON:000123491.63gold quality
left adrenal gland cortexUBERON:003582591.50gold quality
germinal epithelium of ovaryUBERON:000130491.34gold quality
mucosa of paranasal sinusUBERON:000503090.88gold quality
bronchial epithelial cellCL:000232890.78gold quality
entorhinal cortexUBERON:000272890.73gold quality
cardiac muscle of right atriumUBERON:000337990.59silver quality
right adrenal glandUBERON:000123390.39gold quality
superior frontal gyrusUBERON:000266190.39gold quality
bronchusUBERON:000218590.30gold quality
middle temporal gyrusUBERON:000277189.62gold quality
parotid glandUBERON:000183189.45gold quality
heart right ventricleUBERON:000208089.25gold quality
adrenal glandUBERON:000236989.07gold quality
endothelial cellCL:000011588.98gold quality
medial globus pallidusUBERON:000247788.92gold quality
primary visual cortexUBERON:000243688.78gold quality
tibiaUBERON:000097988.52gold quality
occipital lobeUBERON:000202188.21gold quality
tendon of biceps brachiiUBERON:000818888.17gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-HCAD-38yes427.95
E-GEOD-81608yes16.45
E-ANND-3yes14.21
E-GEOD-99795no3.39

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

48 targeting TMEM150C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-574-5P100.0066.01989
HSA-MIR-3163100.0077.238605
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-23A-3P99.9574.243163
HSA-MIR-23B-3P99.9574.243163
HSA-MIR-23C99.9573.923192
HSA-MIR-96-5P99.9572.802140
HSA-MIR-218-5P99.9372.222103
HSA-MIR-335-3P99.9373.364958
HSA-MIR-1213399.9271.822006
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-1271-5P99.9171.991972
HSA-MIR-605-3P99.8869.221833
HSA-MIR-182-5P99.8774.032589
HSA-MIR-30A-3P99.8769.742928
HSA-MIR-30D-3P99.8769.922917
HSA-MIR-30E-3P99.8769.682942
HSA-MIR-684499.8270.692423
HSA-MIR-63699.8069.581500
HSA-MIR-467999.7669.191229
HSA-MIR-430699.7270.503630
HSA-MIR-377-5P99.7065.28712
HSA-MIR-608699.7065.38699
HSA-MIR-453099.6966.471509
HSA-MIR-432899.5771.064094
HSA-MIR-92B-5P99.3663.29110
HSA-MIR-464499.3569.122514
HSA-MIR-185-5P99.3568.602497
HSA-MIR-942-3P98.8169.04876

Literature-anchored findings (GeneRIF, showing 2)

  • Exploring Piezo1, Piezo2, and TMEM150C in human brain tissues and their correlation with brain biomechanical characteristics. (PMID:38124148)
  • Tentonin 3 is a pore-forming subunit of a slow inactivation mechanosensitive channel. (PMID:38850532)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriotmem150cENSDARG00000069590
mus_musculusTmem150cENSMUSG00000050640
rattus_norvegicusTmem150cENSRNOG00000002258
caenorhabditis_elegansWBGENE00008709

Paralogs (4): DRAM1 (ENSG00000136048), DRAM2 (ENSG00000156171), TMEM150A (ENSG00000168890), TMEM150B (ENSG00000180061)

Protein

Protein identifiers

Transmembrane protein 150CB9EJG8 (reviewed: B9EJG8)

Alternative names: Tentonin 3

All UniProt accessions (3): B9EJG8, D6RAQ9, D6RDW6

UniProt curated annotations — full annotation on UniProt →

Function. Nonselective cationic channel with high permeability to Ca(2+). Component of a mechanosensitive cation channel, confers mechanically activated (MA) currents with slow inactivation kinetics. May contribute to proprioception.

Subcellular location. Cell membrane. Lysosome membrane.

Miscellaneous. Tentonin comes from the Greek ’tentono’ meaning to stretch.

Similarity. Belongs to the DRAM/TMEM150 family.

Isoforms (2)

UniProt IDNamesCanonical?
B9EJG8-11yes
B9EJG8-22

RefSeq proteins (3): NP_001073975, NP_001340383, NP_001340384 (=MANE)

Domains & families (InterPro)

IDNameType
IPR019402CWH43_NDomain
IPR050911DRAM/TMEM150_Autophagy_ModFamily

Pfam: PF10277

Catalyzed reactions (Rhea), 4 shown:

  • K(+)(in) = K(+)(out) (RHEA:29463)
  • Ca(2+)(in) = Ca(2+)(out) (RHEA:29671)
  • Mg(2+)(in) = Mg(2+)(out) (RHEA:29827)
  • Na(+)(in) = Na(+)(out) (RHEA:34963)

UniProt features (17 total): topological domain 7, transmembrane region 6, sequence conflict 2, chain 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-B9EJG8-F191.570.83

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 89 (showing top): GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP, GOCC_VACUOLAR_MEMBRANE, GOBP_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS, GOZGIT_ESR1_TARGETS_DN, CHANDRAN_METASTASIS_DN, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN, GOBP_SENSORY_PERCEPTION, GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE, CUI_TCF21_TARGETS_2_DN, GOBP_NEUROMUSCULAR_PROCESS, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_RESPONSE_TO_MECHANICAL_STIMULUS, CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP

GO Biological Process (3): proprioception (GO:0019230), cellular response to mechanical stimulus (GO:0071260), monoatomic cation transmembrane transport (GO:0098655)

GO Molecular Function (1): mechanosensitive monoatomic cation channel activity (GO:0140135)

GO Cellular Component (5): lysosomal membrane (GO:0005765), plasma membrane (GO:0005886), lysosome (GO:0005764), endomembrane system (GO:0012505), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
sensory perception1
neuromuscular process controlling posture1
response to mechanical stimulus1
cellular response to abiotic stimulus1
cellular response to external stimulus1
monoatomic cation transport1
monoatomic ion transmembrane transport1
monoatomic cation channel activity1
mechanosensitive monoatomic ion channel activity1
lysosome1
lytic vacuole membrane1
membrane1
cell periphery1
lytic vacuole1
vacuole1
plasma membrane1

Protein interactions and networks

STRING

400 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMEM150CPIEZO1Q92508667
TMEM150CPIEZO2Q9H5I5623
TMEM150CTMEM120AQ9BXJ8542
TMEM150CTMEM221A6NGB7484
TMEM150CPHACTR2O75167472
TMEM150CGPRC5CQ9NQ84447
TMEM150CKCNK2O95069435
TMEM150CTRPV4Q9HBA0425
TMEM150CLHFPL7Q6ICI0420
TMEM150CTMEM87AQ8NBN3413
TMEM150CGPR137CQ8N3F9410
TMEM150CTMEM63CQ9P1W3399
TMEM150COVOL3O00110390
TMEM150CTMEM132EQ6IEE7387
TMEM150CASIC2Q16515378

IntAct

0 interactions, top by confidence:

BioGRID (15): TMEM150C (Affinity Capture-RNA), TMEM150C (Positive Genetic), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), TMEM150C (Co-fractionation), USP39 (Co-fractionation)

ESM2 similar proteins: A2AE42, A3A9H6, A5D7C9, A5D9A7, A6NM10, B3SHH9, B5DFH9, B9EJG8, F1NZP5, O14569, P10897, P49447, P82352, Q08DE1, Q14714, Q148G2, Q3ZCD2, Q5E965, Q5ND56, Q5RCZ2, Q5U2W7, Q5ZJX0, Q60720, Q62147, Q641Y1, Q6GPL4, Q6P0C6, Q6P1H1, Q71RH2, Q7TNV1, Q80ZE4, Q86TG1, Q8BMD6, Q8C8S3, Q8IXF9, Q8N8Q1, Q8NBI2, Q8TBR7, Q8VHW3, Q8VHW7

Diamond homologs: A5D7C9, A6NC51, A9JSP6, B5DFH9, B9EJG8, Q28BP2, Q32PK2, Q3ZC48, Q4V7T3, Q4V7T7, Q6UX65, Q8C8S3, Q8R218, A7MBB3, Q5BK09, Q6GPL4, Q86TG1, Q91WN2, Q9CR48, Q9DC58, Q9QZE9, Q8N682, Q5EAK8, Q6NRS6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

29 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance23
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1836 predictions. Top by Δscore:

VariantEffectΔscore
4:82502793:TG:Tacceptor_gain1.0000
4:82502796:T:Cacceptor_gain1.0000
4:82502796:T:TCacceptor_gain1.0000
4:82504570:ATACT:Adonor_loss1.0000
4:82504571:TAC:Tdonor_loss1.0000
4:82504572:AC:Adonor_loss1.0000
4:82504573:CTCA:Cdonor_loss1.0000
4:82504575:C:CCdonor_loss1.0000
4:82504576:A:ACdonor_gain1.0000
4:82504577:C:CCdonor_gain1.0000
4:82504577:CA:Cdonor_gain1.0000
4:82504577:CACT:Cdonor_gain1.0000
4:82504663:TACCA:Tacceptor_gain1.0000
4:82504664:ACCA:Aacceptor_gain1.0000
4:82504665:CCA:Cacceptor_gain1.0000
4:82504665:CCAC:Cacceptor_gain1.0000
4:82504666:CA:Cacceptor_gain1.0000
4:82504666:CAC:Cacceptor_gain1.0000
4:82504668:C:CCacceptor_gain1.0000
4:82504668:CTGAA:Cacceptor_loss1.0000
4:82490118:T:Adonor_gain0.9900
4:82490240:T:Cacceptor_gain0.9900
4:82495752:AAC:Adonor_gain0.9900
4:82502722:CTTA:Cdonor_loss0.9900
4:82502724:TACCT:Tdonor_loss0.9900
4:82502790:CAATG:Cacceptor_gain0.9900
4:82502792:ATG:Aacceptor_gain0.9900
4:82502795:C:CCacceptor_gain0.9900
4:82502926:TC:Tacceptor_gain0.9900
4:82502927:CC:Cacceptor_gain0.9900

AlphaMissense

1627 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
4:82496071:A:CF120L1.000
4:82496071:A:TF120L1.000
4:82496073:A:GF120L1.000
4:82496093:C:TG113E1.000
4:82485667:C:AW198C0.999
4:82485667:C:GW198C0.999
4:82485669:A:GW198R0.999
4:82485669:A:TW198R0.999
4:82490169:A:GW145R0.999
4:82490169:A:TW145R0.999
4:82490183:C:TG140D0.999
4:82490207:C:AG132V0.999
4:82490207:C:TG132E0.999
4:82490208:C:GG132R0.999
4:82490208:C:TG132R0.999
4:82490217:G:CH129D0.999
4:82496074:A:CN119K0.999
4:82496074:A:TN119K0.999
4:82496078:C:AG118V0.999
4:82496078:C:TG118D0.999
4:82496079:C:GG118R0.999
4:82496093:C:AG113V0.999
4:82496094:C:GG113R0.999
4:82496094:C:TG113R0.999
4:82496174:C:GR86P0.999
4:82502743:G:CN73K0.999
4:82502743:G:TN73K0.999
4:82502758:A:CF68L0.999
4:82502758:A:TF68L0.999
4:82502760:A:GF68L0.999

dbSNP variants (sampled 300 via entrez): RS1000029670 (4:82528846 G>A), RS1000044853 (4:82523290 A>G), RS1000065033 (4:82530295 A>C,T), RS10001408 (4:82507270 T>C), RS1000160956 (4:82535679 G>C), RS1000174255 (4:82492132 G>C,T), RS1000229580 (4:82499655 G>A), RS10002527 (4:82508700 A>T), RS1000274159 (4:82542021 C>T), RS1000285945 (4:82492113 G>A,T), RS1000294917 (4:82498985 CTT>C), RS1000328805 (4:82549603 A>G), RS1000346980 (4:82499332 G>T), RS1000358140 (4:82529074 G>A), RS1000375933 (4:82542954 A>G)

Disease associations

OMIM: gene MIM:617292 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidincreases expression3
Phenylmercuric Acetateaffects cotreatment, decreases expression2
S-(1,2-dichlorovinyl)cysteineaffects cotreatment, decreases expression, affects response to substance, increases expression1
mercuric bromidedecreases expression, affects cotreatment1
perfluoro-n-nonanoic aciddecreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamidedecreases expression, affects cotreatment1
abrinedecreases expression1
Grape Seed Proanthocyanidinsaffects cotreatment, decreases expression1
dorsomorphinaffects cotreatment, decreases expression1
Acetaminophenincreases expression1
Vehicle Emissionsdecreases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Cadmiumdecreases expression, increases abundance1
Catechindecreases expression, affects cotreatment1
Coumestroldecreases expression1
Diethylhexyl Phthalatedecreases expression1
Dimethyl Sulfoxideaffects expression1
Estradioldecreases expression1
Fluorouracildecreases expression1
Lipopolysaccharidesaffects cotreatment, decreases expression, affects response to substance, increases expression1
Silicon Dioxidedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoinincreases expression1
Triclosandecreases expression1
Aflatoxin B1increases methylation1
Cadmium Chloridedecreases expression, increases abundance1
Okadaic Aciddecreases expression1
Particulate Matteraffects expression1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_TS79HAP1 TMEM150C (-) 1Cancer cell lineMale
CVCL_TS80HAP1 TMEM150C (-) 2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.